BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38365286)

  • 1. Investigating the association between genetically proxied circulating levels of immune checkpoint proteins and cancer survival: protocol for a Mendelian randomisation analysis.
    Bate T; Martin RM; Yarmolinsky J; Haycock PC
    BMJ Open; 2024 Feb; 14(2):e075981. PubMed ID: 38365286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
    PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
    Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
    PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
    Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
    Elife; 2022 Mar; 11():. PubMed ID: 35346416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.
    Khankari NK; Shu XO; Wen W; Kraft P; Lindström S; Peters U; Schildkraut J; Schumacher F; Bofetta P; Risch A; Bickeböller H; Amos CI; Easton D; Eeles RA; Gruber SB; Haiman CA; Hunter DJ; Chanock SJ; Pierce BL; Zheng W; ; ; ;
    PLoS Med; 2016 Sep; 13(9):e1002118. PubMed ID: 27598322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of mendelian randomization for investigating drug effects.
    Gill D; Burgess S
    PLoS Med; 2022 Feb; 19(2):e1003898. PubMed ID: 35113864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
    Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
    Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants.
    Larsson SC; Carter P; Kar S; Vithayathil M; Mason AM; Michaëlsson K; Burgess S
    PLoS Med; 2020 Jul; 17(7):e1003178. PubMed ID: 32701947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants.
    Chen Y; Xie Y; Ci H; Cheng Z; Kuang Y; Li S; Wang G; Qi Y; Tang J; Liu D; Li W; Yang Y
    BMC Med; 2024 Mar; 22(1):90. PubMed ID: 38433226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer.
    Yarmolinsky J; Bull CJ; Vincent EE; Robinson J; Walther A; Smith GD; Lewis SJ; Relton CL; Martin RM
    JAMA; 2020 Feb; 323(7):646-655. PubMed ID: 32068819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
    Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
    EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between circulating vitamin E and ten common cancers: evidence from large-scale Mendelian randomization analysis and a longitudinal cohort study.
    Xin J; Jiang X; Ben S; Yuan Q; Su L; Zhang Z; Christiani DC; Du M; Wang M
    BMC Med; 2022 May; 20(1):168. PubMed ID: 35538486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study.
    Zhao JV; Liu F; Schooling CM; Li J; Gu D; Lu X
    Diabetologia; 2022 Apr; 65(4):695-704. PubMed ID: 35080656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-Sample Mendelian Randomization Analysis of Associations Between Periodontal Disease and Risk of Cancer.
    Corlin L; Ruan M; Tsilidis KK; Bouras E; Yu YH; Stolzenberg-Solomon R; Klein AP; Risch HA; Amos CI; Sakoda LC; Vodička P; Rish PK; Beck J; Platz EA; Michaud DS
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34222791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis.
    Wang K; Shi M; Huang C; Fan B; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Cardiovasc Diabetol; 2022 Sep; 21(1):192. PubMed ID: 36151532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer.
    Gao C; Patel CJ; Michailidou K; Peters U; Gong J; Schildkraut J; Schumacher FR; Zheng W; Boffetta P; Stucker I; Willett W; Gruber S; Easton DF; Hunter DJ; Sellers TA; Haiman C; Henderson BE; Hung RJ; Amos C; Pierce BL; Lindström S; Kraft P;
    Int J Epidemiol; 2016 Jun; 45(3):896-908. PubMed ID: 27427428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.